Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy

MLA

Jean-Louis A. Parmasad, et al. “Genetic and Pharmacological Reduction of CDK14 Mitigates Synucleinopathy.” Cell Death and Disease, vol. 15, no. 4, Apr. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41419-024-06534-8.

APA

Jean-Louis A. Parmasad, Konrad M. Ricke, Benjamin Nguyen, Morgan G. Stykel, Brodie Buchner-Duby, Amanda Bruce, Haley M. Geertsma, Eric Lian, Nathalie A. Lengacher, Steve M. Callaghan, Alvin Joselin, Julianna J. Tomlinson, Michael G. Schlossmacher, William L. Stanford, Jiyan Ma, Patrik Brundin, Scott D. Ryan, & Maxime W. C. Rousseaux. (2024). Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy. Cell Death and Disease, 15(4), 1–13. https://doi.org/10.1038/s41419-024-06534-8

Chicago

Jean-Louis A. Parmasad, Konrad M. Ricke, Benjamin Nguyen, Morgan G. Stykel, Brodie Buchner-Duby, Amanda Bruce, Haley M. Geertsma, et al. 2024. “Genetic and Pharmacological Reduction of CDK14 Mitigates Synucleinopathy.” Cell Death and Disease 15 (4): 1–13. doi:10.1038/s41419-024-06534-8.